Target intelligence / Profile preview

Arf-GAP domain and FG repeat-containing protein 1 (AGFG1)

Target
AGFG1
Molecular classification
Vesicular trafficking regulator, Nucleoporin-like protein, Clathrin adaptor protein, Other
01

Overview

Arf-GAP domain and FG repeat-containing protein 1 (AGFG1) is a nucleoporin-related protein that regulates vesicular trafficking and nucleocytoplasmic transport in mammalian cells[1][3][4]. AGFG1 is essential for the docking and fusion of proacrosomic vesicles during sperm development; its absence causes acrosome loss and male infertility[1]. It acts as a clathrin adaptor and mediates retrieval and recycling of SNARE proteins such as VAMP7 via clathrin-coated vesicles[1]. Importantly, AGFG1 is a critical host factor for HIV-1 and Influenza A virus replication, required for the nuclear export of viral RNAs through direct interaction with the HIV-1 Rev protein[2][3]. AGFG1 localizes mainly at the perinuclear region, plasma membrane, and cytoplasm, and may play a broader role in RNA and protein transport, with evidence of interaction with adaptors such as EPS15[2][3]. AGFG1 is nonessential for general cell survival but is indispensable for specific trafficking processes and viral lifecycles.

Other names
HRBRIPRABHIV-1 Rev-binding proteinNucleoporin-like protein RIPRev-interacting proteinRev/Rex activation domain-binding proteinhRIPArfGAP with FG repeats 1
02

Mechanism of action

Not classically drugged, but viral proteins (notably HIV-1 Rev) bind and exploit AGFG1 for nuclear export of incompletely spliced RNAs[1][2][3][4]. Targeting the AGFG1-Rev interaction has been proposed as an antiviral strategy[2].

03

Biological functions

Nucleocytoplasmic transportVesicle docking and fusionClathrin-mediated endocytosisRegulation of RNA export (especially HIV-1 and viral RNAs)Sperm development (acrosome formation)
04

Disease associations

Infection (HIV-1 and Influenza A replication cofactor)Male infertility (due to defective acrosome formation)Other (potential, based on trafficking and transport roles)
05

Safety considerations

Essential for male fertility in mice, so inhibition may risk infertility[1].Not required for general cellular viability, suggesting some therapeutic window possible in targeting infection[2].

Beyond the preview

Go deeper on Arf-GAP domain and FG repeat-containing protein 1 (AGFG1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arf-GAP domain and FG repeat-containing protein 1 (AGFG1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call